TJI: In September 2009, Biosyntec, a French independent biotechnological company, signed a conditional contract to purchase a 60 per cent stake in Zakłady Tytoniowe w Lublinie (ZTL) for around PLN 24 million (EUR 6 million), but failed to pay for the acquisition at a first deadline in February 2010, and a second deadline in June 2010. Mr Maj, what are the reasons behind the withdrawal of Biosyntec’s offer to acquire a controlling stake of ZTL? |
